Finoriq research workspace
Embecta Corp. (EMBC) Historical Metrics
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of. Review EMBC fundamentals, ratios, and historical filing metrics on Finoriq.
Company Snapshot
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
- Company
- Embecta Corp. (EMBC)
- Ticker
- EMBC
- Market Cap
- $203.8M
- Latest Price
- $3.435
- Industry
- Medical Devices
Embecta Corp. (EMBC) Current Valuation Metrics
Static valuation preview for Embecta Corp. (EMBC). Market data retrieved 2026-07-09. Filing currency USD.
| Metric | Value | Source |
|---|---|---|
| P/EMarket cap divided by latest TTM net income. | 1.35x | Net Income | TTM Q1 2026 |
| P/SMarket cap divided by latest TTM revenue. | 0.17x | Revenue | TTM Q1 2026 |
| P/Operating Cash FlowMarket cap divided by latest TTM operating cash flow. | 0.88x | Operating Cash Flow | TTM Q1 2026 |
| Earnings YieldLatest TTM net income divided by market cap. | 73.9% | Net Income | TTM Q1 2026 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | 113.5% | Operating Cash Flow | TTM Q1 2026 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.